BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201201T110000
DTEND;TZID=Europe/London:20201201T120000
DTSTAMP:20260421T235417
CREATED:20200921T104423Z
LAST-MODIFIED:20200921T104423Z
UID:18367-1606820400-1606824000@staging.medilinkmidlands.com
SUMMARY:CANCELLED Webinar: GDPR implications for international personal data transfers
DESCRIPTION:[box type=”shadow” align=”” class=”” width=””]We have unfortunately had to cancel this webinar due to circumstances beyond our control. We sincerely apologise for this inconvenience.  [/box] \nEarlier this year\, the European Court of Justice struck down the US Privacy Shield\, and although it focused on EU-US data transfers\, the ruling has caused widespread aftershocks for international personal data transfers within the EEA. International group companies using personal data\, or even non-international organisations which are using Cloud or other service providers in non-EEA countries (such as India or elsewhere)\, need to be aware of the implications arising from the ruling. \nFor life sciences businesses\, the kinds of data that may be affected could be data about individual patients and their treatment\, clinical trial data and information about staff\, research colleagues and physicians. Organisations have become so used to working digitally that they may not even fully appreciate when international data transfers are taking place. \nJagvinder Singh Kang\, International and UK Head of IT Law (CIPP/E\, CIPM) at Mills & Reeve considers what steps you can take to protect your organisation following the ruling. \nThis webinar will be relevant to all organisations involved in international personal data transfers from within the EEA\, whether to group companies\, service providers or other organisations. \nThere will also be an opportunity to ask the presenters questions\, when Jagvinder will be joined for a Q&A session by specialist Life Sciences Lawyer\, Stephanie Caird. \nDURATION: 1 hour \nPlease note that due to privacy restrictions this webinar will NOT be recorded and the presentation slides will not be available to download. \nThis free to attend webinar will be held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund. For further details please click here. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSPEAKER PROFILES: \n Jagvinder Singh Kang – International and UK Head of IT (CIPP/E\, CIPM) \nJagvinder is a market leading technology lawyer. He is featured in Legal 500’s official ‘Hall of Fame’ – which Legal 500 confirms: “highlights\, to clients\, the law firm partners who are at the pinnacle of the profession.” He has been recognised for 9 consecutive years in Legal 500’s ‘Elite List of Outstanding Technology Lawyers Nationwide’\, and consistently been ranked number one for IT and technology law by Legal 500 and Chambers & Partners for the same period. Jagvinder is a specialist technology and GDPR/data protection lawyer (CIPP/E\, CIPM)\, as well as a qualified software engineer (First Class BSc (Hons) Computer Science & Software Engineering) and he has completed the academic requirements for Chartered Engineer status as well. Furthermore\, he has over 20 years of technology law expertise from having advised on billions of pounds worth of UK and international technology transactions\, involving FTSE 100\, NASDAQ listed and other world-class corporates. He has also undertaken global\, European and UK GDPR compliance projects. \n  \n \nStephanie Caird – Commercial Lawyer \nStephanie is a lawyer in the life sciences practice\, with significant experience in data protection\, intellectual property\, commercial contracting and regulatory work. She supports a wide range of clients in the pharma and biotech\, medical devices and diagnostic sectors. Stephanie has worked in-house in various life sciences organisations\, giving her a unique insight into her clients. She uses this experience to deliver pragmatic and commercial advice. A key focus of her work is supporting clients on strategic decisions influenced by the regulatory framework and contracts covering IP\, research collaborations and Brexit related intra-group arrangements. \n 
URL:https://staging.medilinkmidlands.com/event/webinar-gdpr-implications-for-international-personal-data-transfers/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/erdflogo2.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201201T110000
DTEND;TZID=Europe/London:20201201T120000
DTSTAMP:20260421T235417
CREATED:20201007T131912Z
LAST-MODIFIED:20201007T131912Z
UID:18384-1606820400-1606824000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: The Medicines and Medical Devices Bill - the UK regulatory environment following Brexit
DESCRIPTION:Join Mills & Reeve for this webinar where we will discuss the Medicines and Medical Devices Bill – the UK regulatory environment following Brexit. \nAs the end of the Brexit transition period approaches we see UK Government making plans to move forward as a standalone regulatory system. A central plank of these plans is the Medicines and Medical Devices Bill. This was published in February\, and is making its way through the Parliamentary process. Although existing EU law will be brought over into the UK system from 1 January 2021\, the Bill gives broad powers to the Health Minister to develop the law to fit UK priorities. Promoting fast-track approval of innovative medicines and technologies and reducing red tape\, as well as promoting UK-based industry\, will take on greater importance. \nFor medical devices\, the situation is made more complex by the forthcoming full implementation of the new EU regulations on medical devices and in vitro diagnostics. Likewise\, the EU clinical trials system is yet to be rolled out pending completion of the EMA’s new portal and database. The UK will have to decide how closely to track these systems\, while\, of course\, adopting its own administrative structures to implement them. \nDuring this webinar we will review the latest position\, and consider likely outcomes for the UK regulatory environment. \nThere will also be an opportunity to ask the presenters questions. \nDURATION: 1 hour \nThis free to attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n \nJames Fry\, Head of Life Sciences and Partner at Mills & Reeve \nJames heads the firm’s fast growing\, multi-disciplinary life sciences practice and focuses exclusively on this sector. The practice supports clients in the pharma and biotech\, medical device\, diagnostic\, medtech and digital health sub-sectors. James’ own practice focuses on intellectual property\, commercial contracting and regulatory work. \n  \n  \n  \n \nIsabel Teare\, Senior Legal Adviser at Mills & Reeve \nIsabel Teare is a Senior Legal Adviser at Mills & Reeve. She started her career in molecular biology\, and focuses on all aspects of life sciences law and regulation. \n  \n  \n  \n  \n 
URL:https://staging.medilinkmidlands.com/event/webinar-the-medicines-and-medical-devices-bill-the-uk-regulatory-environment-following-brexit/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/isabel-teare.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201209T110000
DTEND;TZID=Europe/London:20201209T120000
DTSTAMP:20260421T235417
CREATED:20201026T114838Z
LAST-MODIFIED:20201026T114838Z
UID:18413-1607511600-1607515200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Medtech Regulatory Special Interest Group (SIG) - Keeping Up With The Ever Changing Regulations
DESCRIPTION:The next Medtech Regulatory Special Interest Group (SIG) will take place online. Join us as we remove the confusion from the ever changing regulations including MDD\, IVDD\, AIMDD\, MDR\, IVDR\, UKCA & MRA\, and what it means to us in the UK. \nThe topics being discussed are:\n– Really Brief history of the Directives and their resurrected future: MDD\, IVDD\, AIMDD\n– The new MDR – current time line (less than 6 months to go)\n– The new IVDR – growing calls for a delay\n– The new UKCA Mark – for GB only!\n– What regulation applies to me?\n– Finding a Notified Body/ UK Approved Body \nThere will also be an opportunity to ask the presenter questions in a Q&A session. \nThis free to attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \n  \nSpeaker Profile \nPeter Rose\, Managing Director\, PRQR Ltd \nPeter is the founder of PRQR Ltd. With 26 years of experience with Medical Devices and IVDs\, Peter has expertise covering Quality Assurance\, Regulatory Affairs\, Sterilisation\, Cleanrooms and Contamination Control. He is a Microbiologist\, Chartered biologist\, Member of the RSB\, Practitioner Member of the CQI and a Member of TOPRA. \n  \n  \n 
URL:https://staging.medilinkmidlands.com/event/medtech-regulatory-special-interest-group-sig-keeping-up-with-the-ever-changing-regulations/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/erdflogo2.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
END:VCALENDAR